Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: implications for plateauing weight loss in response to anti-obesity therapies
In Mexico, where obesity, diabetes, and cardiovascular diseases remain deeply connected to public health challenges, these therapies could play an increasingly important role in the future of healthcare , and prepare its healthcare system for a rapidly evolving market.
The cryo-EM map for the oxyntomodulin-bound complex enabled robust modelling and confident assignment of most of the side-chain rotamers for oxyntomodulin, the G protein and the receptor TMD (Supplementary Fig
It is important to distinguish between plasma levels and intracellular red blood cell levels, as most other glutathione products have only shown increases in plasma levels
As the arsenal of incretin therapies targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors continues to expand, clinicians need to balance the myriad clinical benefits with potentially severe adverse effects (AEs) to put this principle into practice
As interest in metabolic optimization grows, the use of targeted peptides such as the Cagrilintide peptide is gaining popularity in aesthetic and weight management circles